Literature DB >> 12369817

Biochemical characterization and structural analysis of a highly proficient cocaine esterase.

James M Turner1, Nicholas A Larsen, Amrik Basran, Carlos F Barbas, Neil C Bruce, Ian A Wilson, Richard A Lerner.   

Abstract

The bacterial cocaine esterase, cocE, hydrolyzes cocaine faster than any other reported cocaine esterase. Hydrolysis of the cocaine benzoyl ester follows Michaelis-Menten kinetics with k(cat) = 7.8 s(-1) and K(M) = 640 nM. A similar rate is observed for hydrolysis of cocaethylene, a more potent cocaine metabolite that has been observed in patients who concurrently abuse cocaine and alcohol. The high catalytic proficiency, lack of observable product inhibition, and ability to hydrolyze both cocaine and cocaethylene make cocE an attractive candidate for rapid cocaine detoxification in an emergency setting. Recently, we determined the crystal structure of this enzyme, and showed that it is a serine carboxylesterase, with a catalytic triad formed by S117, H287, and D259 within a hydrophobic active site, and an oxyanion hole formed by the backbone amide of Y118 and the Y44 hydroxyl. The only enzyme previously known to use a Tyr side chain to form the oxyanion hole is prolyl oligopeptidase, but the Y44F mutation of cocE has a more deleterious effect on the specificity rate constant (k(cat)/K(M)) than the analogous Y473F mutation of prolyl oligopeptidase. Kinetic studies on a series of cocE mutants both validate the proposed mechanism, and reveal the relative contributions of active site residues toward substrate recognition and catalysis. Inspired by the anionic binding pocket of the cocaine binding antibody GNC92H2, we found that a Q55E mutation within the active site of cocE results in a modest (2-fold) improvement in K(M), but a 14-fold loss of k(cat). The pH rate profile of cocE was fit to the ionization of two groups (pK(a1) = 7.7; pK(a2) = 10.4) that likely represent titration of H287 and Y44, respectively. We also describe the crystal structures of both S117A and Y44F mutants of cocE. Finally, urea denaturation studies of cocE by fluorescence and circular dichroism show two unfolding transitions (0.5-0.6 M and 3.2-3.7 M urea), with the first transition likely representing pertubation of the active site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369817     DOI: 10.1021/bi026131p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  39 in total

1.  Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination.

Authors:  Tien-Yi Lee; Yoon Shin Park; George A Garcia; Roger K Sunahara; James H Woods; Victor C Yang
Journal:  Mol Pharm       Date:  2012-03-28       Impact factor: 4.939

2.  The carboxylesterase gene family from Arabidopsis thaliana.

Authors:  Sean D G Marshall; Joanna J Putterill; Kim M Plummer; Richard D Newcomb
Journal:  J Mol Evol       Date:  2003-11       Impact factor: 2.395

3.  Repeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.

Authors:  Gregory T Collins; Remy L Brim; Kathleen R Noon; Diwahar Narasimhan; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2012-04-19       Impact factor: 4.030

Review 4.  Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicity.

Authors:  Charles W Schindler; Steven R Goldberg
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 5.  Cocaine hydrolase gene therapy for cocaine abuse.

Authors:  Stephen Brimijoin; Yang Gao
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

6.  Toward cocaine esterase therapeutics.

Authors:  Claude J Rogers; Jenny M Mee; Gunnar F Kaufmann; Tobin J Dickerson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2005-07-20       Impact factor: 15.419

7.  Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.

Authors:  Gregory T Collins; Kathy A Carey; Diwahar Narasimhan; Joseph Nichols; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

8.  Effects of cocaine esterase following its repeated administration with cocaine in mice.

Authors:  Mei-Chuan Ko; Diwahar Narasimhan; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods
Journal:  Drug Alcohol Depend       Date:  2009-02-13       Impact factor: 4.492

9.  A thermally stable form of bacterial cocaine esterase: a potential therapeutic agent for treatment of cocaine abuse.

Authors:  Remy L Brim; Mark R Nance; Daniel W Youngstrom; Diwahar Narasimhan; Chang-Guo Zhan; John J G Tesmer; Roger K Sunahara; James H Woods
Journal:  Mol Pharmacol       Date:  2010-01-19       Impact factor: 4.436

10.  Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity.

Authors:  Daquan Gao; Diwahar L Narasimhan; Joanne Macdonald; Remy Brim; Mei-Chuan Ko; Donald W Landry; James H Woods; Roger K Sunahara; Chang-Guo Zhan
Journal:  Mol Pharmacol       Date:  2008-11-05       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.